First-trimester prenatal screening using nuchal translucency combined with maternal PAPP-A and free #-hCG levels
HAYES, Inc.
Record ID 32006000925
English
Authors' objectives:
First-trimester prenatal screening involves determination of maternal serum free #-human chorionic gonadotropin (hCG) and pregnancy-associated plasma protein A (PAPP-A) levels combined with ultrasonographic measurement of nuchal translucency. The results of these tests, in conjunction with maternal age, are used to calculate patient-specific risk for fetal chromosomal disorders. The goal of first-trimester prenatal screening is to provide risk information early in pregnancy, thereby allowing for additional diagnostic testing and optimal pregnancy management or early termination.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2005
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Chorionic Gonadotropin
- Nuchal Translucency Measurement
- Pregnancy-Associated Plasma Protein-A
- Prenatal Diagnosis
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.